Strategy for treatment of stage IV human epidermal growth factor 2-positive gastric cancer: a case report
ConclusionDCS regimen, R0 resection, and adjuvant chemotherapy with trastuzumab can be a powerful strategy for stage IV HER2-positive gastric cancer.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Cytology | Docetaxel | Gastrectomy | Gastric (Stomach) Cancer | Gastroenterology | General Medicine | HER2 | Herceptin | Japan Health | Laparoscopy | Taxotere